Apheresis services
Award Notice Posted
- Solicitation number
- VA24312R2470
- Agency
-
Veterans Integrated Service Network 2
Veterans Health Administration, Department of Veterans Affairs
- Awarded
- to New York Blood Center, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- VA24313D0019 Federal IDV award
- NAICS code
- 621991 Blood and Organ Banks
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
Notice text
Therapeutic apheresis is used to treat many diseases. The theoretical basis for the therapeutic apheresis is to reduce the patient's load of pathologic substances to levels that will allow improvement. Cells, plasma, or plasma constituents may be removed from the circulation and replaced by normal plasma, crystalloid, colloids such as starch, or albumin. Due to the infrequency of these apheresis procedures the VA Bronx and VA New Jersey Transfusion Medicine service personnel are limited in maintaining certification and expertise to perform them. The need to have a therapeutic apheresis service available upon the order and immediate direction of the medical center's staff physicians when such physicians determine those services are clinically indicated shall the patient be referred for contract service. A contract is needed to make therapeutic apheresis services available at the VA Bronx and VA New Jersey, when other options and treatments have failed or not clinically indicated.
The Contractor shall provide the following therapeutic apheresis services when clinical indicated:
Therapeutic Plasma Exchange (Plasmapheresis)
Therapeutic Cytapheresis:
White cell reduction (Leukapheresis)
Platelet reduction (Plateletcytaphersis)
Red cell exchange/reduction (Erythrocytapheresis)
Immunoadsorption - Prosorda Column Therapy
Files
| File | Type | Posted |
|---|---|---|
| VA243-12-R-2470-000.docx | DOCX document |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity